Bengaluru, Aug. 5 -- Welcure Drugs & Pharmaceuticals Ltd, today announced its financial results for the quarter ended June 30, 2025 (Q1FY26). The company has reported a robust financial performance in the first quarter of FY26, driven by its strategic foray into fee-based, export-oriented sourcing services.

Welcure's revenue from operations rose sharply to Rs 299.91 crores in Q1FY26, up from Rs 21.21 crores previous quarter Q4FY25, making it about 1300% rise on Q-o-Q basis. The company reported Net Profit of Rs 23.29 crores in Q1FY26 as against a net loss of Rs 0.34 crores in the same period last year Q1FY25. The company reported almost 830% rise in Net Profit on Q-o-Q basis when compared to Net Profit of Rs 2.5 crore registered in Q4FY2...